Executives

董事長 巫信弘
Chairman Simon Wu
Education
BS in Chemical Engineering, Tunghai University, Taiwan
Current Position
  1. Chairman, San Fu Chemical Co., Ltd., Taiwan
  2. Chairman, Li Fu Carbon Dioxide Co., Ltd., Taiwan
  3. Directors of the Boards, International Nitto Technology Co., Ltd.; Hongchen Enterprise Co., Ltd.; San Fu Global Co., Ltd.
Experience
  1. President & Vice Chairman, Air Products San Fu Co., Ltd.
  2. Manager & Director, Formosa Chemicals & Fibre Crop.
  3. Chairman, Industrial Gas Association of Taiwan.
總經理 鄭建新
President Daniel C.H. Cheng
Education
PhD in Chemical Engineering, University of Michigan, USA
MS in Chemical Engineering, Oklahoma State University, USA
BS in Chemical Engineering, Tunghai University, Taiwan
Experience
  1. President, PhytoHealth Corp.
  2. VP, Development Center for Biotechnology (DCB), Taiwan.
  3. General Director, Biotechnology & Pharmaceutical Industries Promotion Office (BPIPO), MOEA, Taiwan
  4. Science & Technology Advisor, Department of Industrial Technology, MOEA, Taiwan
  5. Founder, Chairman & President, Caleb Pharmaceuticals, Inc., Taiwan
  6. Senior Researcher & Manager, Laboratory of Controlled Release Technology, Union Chemical Laboratory, ITRI, Taiwan
  7. Adjunct Professor, Department of Chemical Engineering, Tunghai Univ., Taiwan
  8. Manager of R&D, Theratech, Inc. Salt Lake City, Utah, USA
營運長 許榮懷
Chief Operating Officer Alice Hsu
Education
MS in Nutritional Sciences, University of Illinois, USA
MS in International Health, Johns Hopkins University, USA.
BS in Nutrition and Health Sciences, Taipei Medical University
Experience
  1. Senior Vice President, Clinical Technology Services and Consultations ,AlphaLife Sciences Singapore
  2. Vice President, Clinical Technology Services and Consultations, AlphaLife Sciences Shanghai
  3. Senior Director, PPD Shanghai China
  4. Senior Director, WuXi Clinical Development Services (Shanghai) CO.
  5. Project Director, Covance Clinical Development Services, Singapore
  6. Associate Clinical Project Manager, Quintiles Ltd., Taiwan

Management Team

研究發展處處長 劉志鵬
Director of Research and Development Chih-Peng Liu
Education
MS & Ph.D. in Pharmacology, National Yang Ming University, Taiwan
BS in Pharmacy, Taipei Medical College, Taiwan
Experience
  1. Deputy Division Director, Targeted Drug & Delivery Technology Division, BDL, ITRI, Taiwan
  2. Manager, Preclinical Drug Discovery Technology Department, BDL, ITRI, Taiwan
  3. Principal Researcher, BDL, ITRI, Taiwan
  4. Project Director of Technology Development Program, ITRI, Taiwan
臨床運營處處長 施后容
Director of Clinical Operations Nicole Shih
Education
MS in Toxicology, National Taiwan University, Taiwan
BS in Nursing, National Taiwan University, Taiwan
Experience
  1. Product Development Lead, WuXi MedImmune Biopharmaceutical Co. Limited
  2. Director of Clinical Development and Portfolio Management, WuXi Clinical Development Services (Shanghai) CO and Managing Director of Taiwan Branch.
  3. Clinical Project Manager, Quintiles Ltd., Taiwan

Scientific Advisory Board (SAB) for New Drug Development.

We have assembled a Scientific Advisory Board (SAB) composed of senior executives with extensive experience in R&D, clinical development, regulatory affairs, and marketing at leading global pharmaceutical companies, including Abbott, Bayer, Bristol Myers Squibb, Johnson & Johnson, Allergan, and Wyeth. This distinguished group brings a wealth of hands-on expertise in global drug development, providing strategic guidance to our executive leadership and R&D teams.